CDI Lab Earns Grant to Re-engineer Drugs to Combat Emerging   

CDI Lab Earns Grant to Re-engineer Drugs to Combat Emerging Infections

June 23, 2023

A laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) has been issued a major grant to repurpose drugs to combat non-tuberculous mycobacteria (NTM), an emerging family of germs naturally found in soil and water and which can be deadly to those with compromised immune systems and pre-existing lung diseases.

Read more

Cookie Consent

Our website uses cookies. Please review our Privacy Policy to find out more about the cookies we use. Browsing our website means you accept these terms.